Drug Pipeline

GLP-1 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07249554 Combination Therapy for Alcohol Use Disorder Alcohol Use Disorder Not Yet Recruiting
Not specified
NCT01851694 Beta-cell Response to Incretin Hormones in Cystic Fibrosis Cystic Fibrosis Recruiting
NCT07398300 Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP… Type 2 Diabetes Recruiting
NCT07207148 People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists Multiple Sclerosis Recruiting
Sponsors Running GLP-1 Trials
University of Pennsylvania (1) Northwestern University (1) Johns Hopkins University (1) Rigshospitalet, Denmark (1)
Disease Areas
Cystic Fibrosis (1) Multiple Sclerosis (1) Type 2 Diabetes (1) Diabetes (1)
Get alerts when GLP-1 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free